Interactions with Peptostreptococcus

Data Source:

`

There are several ways of doing association. At the bottom is trying linear regression on the percentiles. Doing linear regression of actual counts produce few results. For a blog post describing the process see Bacteria interacting with bacteria.

Above this is the association using Kalthrop-Moldrup Limits (Patent Pending) to determine non parametric association between High Levels and Low Levels. High levels may cause changes in other bacteria (for example, due to amount of natural antibiotics released) but no effect with low levels. Similarly the reverse.

Chi2 is truncated to 10000. Example Expected Count was 13.4, observed was 540


Calculated from Fy(y)=a + (slope) Fx(x). F(x) are custom monotonic functions. See this post for technical notes on computation

RankBacteriaSlope
Relative Impact
Percentage ExplainedImpact
family Campylobacteraceae 44.6% 20.9% 9.3%
family Clostridiales Family XI. Incertae Sedis 52% 36% 18.7%
family Corynebacteriaceae 45.3% 19.9% 9%
family Peptoniphilaceae 46.7% 22.8% 10.7%
genus Anaerococcus 52% 27.4% 14.2%
genus Campylobacter 47% 20.6% 9.7%
genus Corynebacterium 45.2% 19.9% 9%
genus Fastidiosipila 71.2% 51.7% 36.8%
genus Finegoldia 54.7% 28.7% 15.7%
genus Parvimonas 51.3% 26.1% 13.4%
genus Peptoniphilus 43.8% 19.3% 8.5%
genus Solobacterium 48.2% 27.2% 13.1%
genus Varibaculum 45.1% 20.9% 9.4%
no rank unclassified Atopobium 41.8% 22.2% 9.3%
no rank unclassified Peptococcus 41.7% 34% 14.2%
no rank unclassified Porphyromonas 49.8% 33.4% 16.6%
order Campylobacterales 44.2% 20.6% 9.1%
order Tissierellales 46.5% 22.4% 10.4%
phylum Campylobacterota 43.5% 19.8% 8.6%
species Anaerococcus murdochii 52.8% 25.1% 13.3%
species Anaerococcus octavius 43.9% 19.8% 8.7%
species Anaerococcus sp. S8 87-3 45.7% 18.8% 8.6%
species Anaerococcus vaginalis 46.9% 22% 10.3%
species Dialister propionicifaciens 51.7% 26.3% 13.6%
species Finegoldia magna 53.4% 27.4% 14.6%
species Hoylesella timonensis 55.1% 27.7% 15.3%
species Mobiluncus curtisii 53% 27.2% 14.4%
species Peptococcus sp. S9 Pr-12 74.3% 47.8% 35.5%
species Peptoniphilus lacrimalis 52% 28.8% 15%
species Peptoniphilus sp. 2002-38328 46.4% 23.5% 10.9%
species Peptoniphilus sp. BV3AC2 61.5% 41.6% 25.6%
species Peptoniphilus sp. gpac018A 47.6% 24.3% 11.6%
species Peptoniphilus sp. S4-A10 70.6% 19.3% 13.6%
species Peptostreptococcus anaerobius 84.3% 78.3% 66%
species Peptostreptococcus stomatis 78.4% 64% 50.2%
species Porphyromonas somerae 51.5% 26.1% 13.5%
species Porphyromonas sp. 2024b 54.9% 29.6% 16.3%
species Prevotella bivia 51.9% 26.3% 13.6%
species Prevotella disiens 69.9% 43.9% 30.7%
species Schaalia turicensis 43.4% 20.4% 8.8%
species Solobacterium moorei 49.7% 28.4% 14.1%
species Varibaculum sp. CCUG 45114 47.9% 25.5% 12.2%

This is an Academic site. It generates theoretical models of what may benefit a specific microbiome results.

Copyright 2016-2024 Lassesen Consulting, LLC [2007], DBA, Microbiome Prescription. All rights served.
Permission to data scrap or reverse engineer is explicitly denied to all users. U.S. Code Title 18 PART I CHAPTER 47 Β§β€―1030, CETS No.185, CFAA
Use of data on this site is prohibited except under written license. There is no charge for individual personal use. Use for any commercial applications or research requires a written license.
Caveat emptor: Analysis and suggestions are based on modelling (and thus infererence) based on studies. The data sources are usually given for those that wish to consider alternative inferences. theories and models.
Inventions/Methodologies on this site are Patent Pending.

Microbiome Prescription do not make any representations that data or analyses available on this site is suitable for human diagnostic purposes, for informing treatment decisions, or for any other purposes and accept no responsibility or liability whatsoever for such use.
This site is not Health Insurance Portability and Accountability Act of 1996 (HIPAA) compliant.


The awesome web hosting site that we use. Try it if you need to host (or unhappy with current provider)